Add like
Add dislike
Add to saved papers

Slow magnetisation relaxation in tetraoxolene-bridged rare earth complexes.

Three families of tetraoxolene-bridged dinuclear rare earth (RE) complexes have been synthesised and characterised, with general formula [((HB(pz)3 )2 RE)2 (μ-tetraoxolene)] (HB(pz)3 - = hydrotris(pyrazolyl)borate; tetraoxolene = chloranilate (1-RE), the dianionic form of 2,5-dihydroxy-1,4-benzoquinone (2-RE), or its 3,6-dimethyl analogue (3-RE)). In each case, the bridging tetraoxolene ligand is in the diamagnetic dianionic form and species with selected lanthanoid(iii) ions from Eu(iii) to Yb(iii) have been obtained, as well as the diamagnetic Y(iii) analogues. Use of the 3,6-dimethyl substituted tetraoxolene ligand (Me2 -dhbq2- ) has also afforded the two byproducts [((HB(pz)3 )(MeOH)(B(OMe)4 )Y)2 (μ-Me2 dhbq)] (4-Y) and [{((HB(pz)3 )(MeOH)Y)2 (μ-B(OMe)4 )}2 (μ-Me2 dhbq)2 ]Cl2 (5-Y), with the B(OMe)4 - ligands arising from partial decomposition of HB(pz)3 - . Electrochemical studies on the soluble 1-RE and 3-RE families indicate multiple tetraoxolene-based redox processes. Magnetochemical and EPR studies of 3-Gd indicate the negligible magnetic coupling between the two Gd(iii) centres through the diamagnetic tetraoxolene bridge. Alternating current magnetic susceptibility studies of 1-Dy and 3-Dy reveal slow magnetic relaxation, with quantum tunnelling of the magnetisation (QTM) dominant in the absence of an applied dc field. The application of a dc field suppresses the QTM and relaxation data are consistent with an Orbach relaxation mechanism playing a major role in both cases, with effective energy barriers to magnetisation reversal determined as 47 and 24 K for 1-Dy and 3-Dy, respectively. The different dynamic magnetic behaviour evident for 1-Dy and 3-Dy arises from small differences in the local Dy(iii) coordination environments, highlighting the subtle structural effects responsible for the electronic structure and resulting magnetic behaviour.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app